4
Changes in Ownership
Candel Therapeutics, Inc. Filed Acc 0001209191-23-040133
Options or other derivatives
- Director acquired 14,240 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Benz Edward J. JR Director | 2023-06-28 | Grant or award · Stock Option (Right to Buy) | +14,240 | 14,240 | D | ||
Loading xslF345X04/doc4.xml…